title: Bridging the gap between the neurocognitive lab and the addiction clinic.
abstract: In the past decennium there has been an enormous increase in new insights in cognitive mechanisms of addiction and their neural substrates. These candidate neurocognitive mechanisms, particularly those associated with "drive" and "control" aspects of addiction, are clearly involved in substance use problems but do not yet provide a full explanation. The neurocognitive mechanisms addressed in the present perspective are attentional bias, reward processing (both drive aspects) and error-processing and cognitive control (both control aspects). The time has come to transfer these recent insights more consistently to clinical practice by studying their relevance for diagnosis and treatment in patient samples. The present perspective echoes the development of recent initiatives such as the RDoC system to integrate developments in neuroscience into clinical practice. The aim of this article is to open new vistas for addiction diagnosis and treatment and to discuss why and how these neurocognitive aspects of addictive behavior can be used in clinical practice. In addition, present problematic issues and a future research agenda are provided.
authors.affiliation: Institute of Psychology, Erasmus University Rotterdam, The Netherlands. Electronic address: franken@fsw.eur.nl.
authors.forename: Ingmar H A
authors.initials: IHA
authors.lastname: Franken
authors.affiliation: Antes/Bouman Mental Health Care, Rotterdam, The Netherlands.
authors.forename: Ben J M
authors.initials: BJM
authors.lastname: van de Wetering
mesh_terms: D001288:Attention; D016739:Behavior, Addictive / Q000175:diagnosis / Q000628:therapy*; D035843:Biomedical Research / Q000379:methods*; D001921:Brain / Q000503:physiopathology*; D003071:Cognition; D000066494:Cognitive Neuroscience / Q000379:methods*; D006801:Humans; D007266:Inhibition, Psychological; D012201:Reward; D016320:Substance Abuse Treatment Centers; D019966:Substance-Related Disorders / Q000175:diagnosis / Q000628:therapy*
keywords: Addiction; EEG/ERPs; Neurocognitive measures; RDoC; fMRI